IDXX · Idexx Laboratories Inc /De
$544.32
+4.96 (+0.92%)
At close · Jul 24
Market Cap
$42.94B
Shares
78.88M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jonathan Mazelsky | CEO | $14,580,122 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $4,019,416 |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | $3,945,293 |
| Martin Smith | CTO | $3,944,534 |
| Andrew Emerson | CFO | $3,033,071 |
| Brian McKeon | CFO | $351,680 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jonathan Mazelsky | CEO | $13,007,051 |
| Brian McKeon | CFO | $3,892,748 |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | $3,730,700 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $3,726,323 |
| Martin Smith | Executive Vice President and Chief Technology Officer | $3,719,059 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jonathan Mazelsky | CEO | $11,519,309 |
| Brian McKeon | CFO | $3,845,065 |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | $3,570,793 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $2,921,361 |
| James F. Polewaczyk | Executive Vice President and Chief Commercial Officer | $2,917,036 |
| Martin Smith | Executive Vice President and Chief Technology Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jonathan Mazelsky | CEO | $9,788,388 |
| Brian McKeon | CFO | $3,510,826 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $2,541,191 |
| James F. Polewaczyk | Executive Vice President and Chief Commercial Officer | $2,540,086 |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | $2,537,863 |
| Martin Smith | Executive Vice President and Chief Technology Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jonathan Mazelsky | CEO | $9,065,021 |
| Brian McKeon | CFO | $3,625,035 |
| James F. Polewaczyk | Executive Vice President and Chief Commercial Officer | $2,592,975 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $2,592,658 |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | $2,583,105 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jonathan Mazelsky | CEO | $7,038,175 |
| Brian McKeon | CFO | $3,350,185 |
| James F. Polewaczyk | Executive Vice President and Chief Commercial Officer | $2,105,700 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $1,909,005 |
| Sharon E. Underberg | General Counsel | $1,881,117 |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jonathan W. Ayers | CEO | $8,188,764 |
| Jonathan Mazelsky | CEO | $7,419,335 |
| Brian McKeon | CFO | $3,940,306 |
| Kathy V. Turner | Senior Vice President and Chief Marketing Officer | $2,696,822 |
| Sharon E. Underberg | General Counsel | $1,809,228 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $1,473,880 |
| James F. Polewaczyk | Executive Vice President and Chief Commercial Officer | — |
| Tina Hunt | Executive Vice President, Strategy, Sector Development and Global Operations | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jonathan W. Ayers | CEO | $6,819,950 |
| Brian McKeon | CFO | $2,905,934 |
| Jonathan Mazelsky | CEO | $2,897,125 |
| Kathy V. Turner | Senior Vice President and Chief Marketing Officer | $1,935,853 |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | $1,357,675 |
| Sharon E. Underberg | General Counsel | — |
| James F. Polewaczyk | Executive Vice President and Chief Commercial Officer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Jonathan W. Ayers | CEO | $6,665,351 |
| Brian McKeon | CFO | $2,422,971 |
| Jonathan Mazelsky | CEO | $2,269,833 |
| Kathy V. Turner | Senior Vice President and Chief Marketing Officer | — |
| Sharon E. Underberg | General Counsel | — |
| Michael J. Lane | Executive Vice President and General Manager, Global Reference Laboratories and Information Technology | — |
Key facts
CIK
874716
CUSIP
45168D104
13F (30d)
337 filings
330 filers
Visit website
Investor relations